Variant report
Variant | nsv1052457 |
---|---|
Chromosome Location | chr11:106477599-106507197 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs55703757 | chr11:106479360-106479361 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs554673797 | chr11:106479426-106479427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576336990 | chr11:106479446-106479447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543726805 | chr11:106479482-106479483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs75662834 | chr11:106479483-106479484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184782731 | chr11:106479485-106479486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1938614 | chr11:106479523-106479524 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs541259077 | chr11:106479648-106479649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570736427 | chr11:106479731-106479732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs559896243 | chr11:106479804-106479805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs527436971 | chr11:106479818-106479819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549024402 | chr11:106479833-106479834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532844908 | chr11:106479834-106479835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188399253 | chr11:106479855-106479856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567154491 | chr11:106479905-106479906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs17105870 | chr11:106479962-106479963 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs72983842 | chr11:106480086-106480087 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs144097818 | chr11:106480094-106480095 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538931193 | chr11:106480114-106480115 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs146499480 | chr11:106480115-106480116 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs565826972 | chr11:106480135-106480136 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536349209 | chr11:106480153-106480154 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs367793482 | chr11:106480161-106480162 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs180811903 | chr11:106480167-106480168 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs559246421 | chr11:106480232-106480233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186570596 | chr11:106480275-106480276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576372639 | chr11:106480320-106480321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs556736378 | chr11:106480348-106480349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543442495 | chr11:106480423-106480424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs558509809 | chr11:106480435-106480436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs189464579 | chr11:106480603-106480604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541319022 | chr11:106480709-106480710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559707685 | chr11:106480773-106480774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535436659 | chr11:106480799-106480800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs372044849 | chr11:106480819-106480820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530267968 | chr11:106480957-106480958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs58969648 | chr11:106480989-106480990 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs376772309 | chr11:106481035-106481036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561004497 | chr11:106481036-106481037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs548032265 | chr11:106481058-106481059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs77432418 | chr11:106481094-106481095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs574946754 | chr11:106481121-106481122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs571253821 | chr11:106481153-106481154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs532457288 | chr11:106481290-106481291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs182217011 | chr11:106481337-106481338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143518458 | chr11:106481370-106481371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs151137063 | chr11:106481380-106481381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs140113282 | chr11:106481471-106481472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs548063689 | chr11:106481475-106481476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570156611 | chr11:106481512-106481513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Obesity | 19966786 | CNVD |
Melanoma | 17363583 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:106479200-106480200 | Enhancers | NHEK | skin |
2 | chr11:106479400-106480200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr11:106479400-106480200 | Enhancers | HMEC | breast |
4 | chr11:106479600-106480200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr11:106480000-106482400 | Weak transcription | Placenta Amnion | Placenta Amnion |
6 | chr11:106482400-106483800 | Enhancers | Placenta Amnion | Placenta Amnion |
7 | chr11:106485000-106485400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr11:106489800-106490400 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr11:106489800-106491800 | Enhancers | Placenta Amnion | Placenta Amnion |
10 | chr11:106491800-106492600 | Weak transcription | Placenta Amnion | Placenta Amnion |
11 | chr11:106492600-106492800 | Enhancers | Placenta Amnion | Placenta Amnion |
12 | chr11:106492800-106493600 | Weak transcription | Placenta Amnion | Placenta Amnion |
13 | chr11:106496000-106496600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
14 | chr11:106496400-106496600 | Enhancers | Placenta Amnion | Placenta Amnion |
15 | chr11:106496400-106496800 | Enhancers | Dnd41 | blood |
16 | chr11:106496400-106497200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr11:106502600-106503600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
18 | chr11:106503400-106505600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |